122 related articles for article (PubMed ID: 28109785)
1. Novel 12N-substituted matrinanes as potential anti-coxsackievirus agents.
Li YH; Tang S; Li YH; Cheng XY; Zhang X; Wang YX; Su F; Song DQ
Bioorg Med Chem Lett; 2017 Feb; 27(4):829-833. PubMed ID: 28109785
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of halogenated 12N-sulfonyl matrinic butanes as potential anti-coxsackievirus agents.
Cheng XY; Li YH; Tang S; Zhang X; Wang YX; Wang SG; Jiang JD; Li YH; Song DQ
Eur J Med Chem; 2017 Jan; 126():133-142. PubMed ID: 27750147
[TBL] [Abstract][Full Text] [Related]
3. SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.
Tang S; Li YH; Cheng XY; Li YH; Wang HQ; Kong LY; Zhang X; Jiang JD; Song DQ
Future Med Chem; 2016 Apr; 8(5):495-508. PubMed ID: 26867658
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of 12N-substituted Tricyclic Matrinic Derivatives as a Novel Family of Anti-Influenza Agents.
Tang S; Li YH; Cheng XY; Yin JQ; Li YH; Song DQ; Wang YX; Liu ZD
Med Chem; 2018; 14(8):764-772. PubMed ID: 29473520
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against Coxsackievirus B.
Zeng QX; Wang HQ; Wei W; Guo TT; Yu L; Wang YX; Li YH; Song DQ
Bioorg Chem; 2020 Jan; 95():103490. PubMed ID: 31855821
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles.
Pürstinger G; De Palma AM; Zimmerhofer G; Huber S; Ladurner S; Neyts J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5123-5. PubMed ID: 18710805
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and biological evaluation of 12-N-benzenesulfonyl matrinic ether derivatives as anti-coxsackievirus B3 agents].
Cheng XY; Tang S; Kong LY; Li YH; Song DQ
Yao Xue Xue Bao; 2016 Apr; 51(4):606-12. PubMed ID: 29859656
[TBL] [Abstract][Full Text] [Related]
11. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hrebabecký H; Nencka R; Dracínský M; Leyssen P; Neyts J; Holý A
Bioorg Med Chem; 2010 Jun; 18(12):4374-84. PubMed ID: 20576576
[TBL] [Abstract][Full Text] [Related]
13. SAR studies of 9-norbornylpurines as Coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hřebabecký H; Dejmek M; Dračínský M; Leyssen P; Neyts J; Mertlíková-Kaiserová H; Nencka R
Bioorg Med Chem Lett; 2011 Jul; 21(14):4271-5. PubMed ID: 21684160
[TBL] [Abstract][Full Text] [Related]
14. QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.
Muratov EN; Varlamova EV; Artemenko AG; Khristova T; Kuz'min VE; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
Future Med Chem; 2011 Jan; 3(1):15-27. PubMed ID: 21428823
[TBL] [Abstract][Full Text] [Related]
15. 2,3,4-Trihydroxybenzyl-hydrazide analogues as novel potent coxsackievirus B3 3C protease inhibitors.
Kim BK; Ko H; Jeon ES; Ju ES; Jeong LS; Kim YC
Eur J Med Chem; 2016 Sep; 120():202-16. PubMed ID: 27191615
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones.
Chern JH; Lee CC; Chang CS; Lee YC; Tai CL; Lin YT; Shia KS; Lee CY; Shih SR
Bioorg Med Chem Lett; 2004 Oct; 14(20):5051-6. PubMed ID: 15380197
[TBL] [Abstract][Full Text] [Related]
17. Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage.
Zhang X; Liu Q; Zhang N; Li QQ; Liu ZD; Li YH; Gao LM; Wang YC; Deng HB; Song DQ
Eur J Med Chem; 2018 Apr; 149():45-55. PubMed ID: 29494844
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Pyrazine-1,3-thiazine Hybrid Analogues as Antiviral Agent Against HIV-1, Influenza A (H1N1), Enterovirus 71 (EV71), and Coxsackievirus B3 (CVB3).
Wu HM; Zhou K; Wu T; Cao YG
Chem Biol Drug Des; 2016 Sep; 88(3):411-21. PubMed ID: 27062664
[TBL] [Abstract][Full Text] [Related]
19. Novel substituted 9-norbornylpurines and their activities against RNA viruses.
Sála M; Hřebabecký H; Leyssen P; Dejmek M; Dračínský M; De Palma AM; Neyts J; Nencka R
Bioorg Med Chem Lett; 2012 Mar; 22(5):1963-8. PubMed ID: 22310228
[TBL] [Abstract][Full Text] [Related]
20. The Evolution of Pleconaril: Modified
Volobueva A; Egorova A; Galochkina A; Ekins S; Zarubaev V; Makarov V
Molecules; 2020 Mar; 25(6):. PubMed ID: 32188089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
